AlphaYou
Overview
Smart money at a glance
Filings to Oct 2, 2026Net selling: insiders sold $309K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$309K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 1 cutEven
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $18.90
- 52-wk high
- $37.50
- High
- $20.00
- 52-wk low
- $16.24
- Low
- $18.85
- Prev close
- $18.82
- Mkt cap
- $3.87B
- Volume
- 2.96M
- Fwd P/E
- 27.6x
- Beta
- 0.40
- P/S
- 3.0x
- P/B
- 2.9x
- Profit margin
- -7.2%
- Op margin
- +14.9%
- ROE
- -8.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about LEGN filings
Are insiders buying or selling Legend Biotech Corp (LEGN) stock?
Net selling: insiders sold $309K and bought $0 of LEGN stock on the open market in the 90 days to Oct 2, 2026, according to SEC Form 4 filings. The largest was Sanders, Corazon (Corsee) D. (Director), who sold $259K. The latest filing was on Oct 1, 2026.
Which members of Congress have traded LEGN recently?
None. No member of Congress disclosed a LEGN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this LEGN smart-money data?
This summary uses filings available on Oct 2, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- TS
Two Sigma
$22.8M
added
- JC
JPMorgan Chase
$17.5M
added
Sells/Trims (1)
- TS
Two Sigma
$29.5M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in LEGN right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 25.0% below what analysts expected.
Earnings per share
$0.12 expected
Reports Nov 11, 2026, in 40 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -7.2%
- Forward P/E
- 27.55
- Market cap
- $3.9B
Valuation
- P/S3.04
- P/B2.92
Quality
- Operating margin14.9%
- ROE-8.1%
- ROA-1.9%
Growth
- Beta0.40
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
35 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace